STUDY OF THE EFFICIENCY AND SAFETY OF MYCOPHENOLATE MOFETIL THERAPY IN PATIENTSWITH SYSTEMIC SCLERODERMA

STUDY OF THE EFFICIENCY AND SAFETY OF MYCOPHENOLATE MOFETIL THERAPY IN PATIENTSWITH SYSTEMIC SCLERODERMA

Interstitial lung disease (ILD) is one of the major causes of death in systemic scleroderma (SSD). Treatment of these patients remains difficult and controversial. Mycophenolate mofetil (MPM) has been in vitro shown to inhibit overproduction of type I collagen and hence may be effective against SSD....

Full description

Bibliographic Details
Main Authors: O A Koneva, L P Ananyeva, O B Ovsyannikova, L V Teplova, M N Starovoitova, O V Desinova, T A Nevskaya, R T Alekperov, E G Lyubimova, L N Denisov
Format: Article
Language:Russian
Published: IMA PRESS LLC 2011-08-01
Series:Научно-практическая ревматология
Subjects:
interstitial lung disease
lung involvement, systemic scleroderma
mycophenolate mofetil
Online Access:https://rsp.mediar-press.net/rsp/article/view/340

Similar Items

Similar Items